Ana I. Stancic
2012
In 2012, Ana I. Stancic earned a total compensation of $1.3M as Former Principal Executive Officer, Executive Vice President, Chief Operating Officer and Chief Financial Officer at Enzon Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Salary | $341,909 |
|---|---|
| Other | $911,026 |
| Total | $1,252,935 |
Stancic received $911K in other compensation, accounting for 73% of the total pay in 2012.
Stancic also received $341.9K in salary.
Rankings
In 2012, Ana I. Stancic's compensation ranked 5,249th out of 11,487 executives tracked by ExecPay. In other words, Stancic earned more than 54.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,249 out of 11,487 | 54th |
Division Manufacturing | 1,838 out of 4,253 | 57th |
Major group Chemicals And Allied Products | 443 out of 1,198 | 63rd |
Industry group Drugs | 290 out of 920 | 69th |
Industry Biological Products, Except Diagnostic Substances | 49 out of 160 | 69th |
Source: SEC filing on October 11, 2013.
Stancic's colleagues
We found five more compensation records of executives who worked with Ana I. Stancic at Enzon Pharmaceuticals in 2012.
2012
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2012
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2012
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2012
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2012
Timothy Daly
Enzon Pharmaceuticals